Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Year-over-year operating income growth rate
Latest
-0.48%
↑ 99% vs avg
Percentile
P67
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-44.44%
Historical baseline
| Period | Value |
|---|---|
| 2025 | -0.48% |
| 2024 | 13.92% |
| 2023 | -185.80% |
| 2022 | -29.14% |
| 2021 | 19.43% |
| 2020 | -1.43% |
| 2019 | -76.70% |
| 2018 | -64.27% |
| 2017 | -26.34% |
| 2016 | -93.60% |